1) type Ⅱ receptor of TGFβ_1
TGFβ1Ⅱ型受体
1.
objective: To establish the vector of truncated type Ⅱ receptor of TGFβ_1eucell expressing plasmid in order to supply the useful experimental materials for the studies of artificial immune rats.
方法:根据大鼠肝组织TGF1βⅡ型受体的基因序列,设计在特异的位置添加终止密码,在此序列两端加入特异的限制性内切酶的酶切位点,从而构建大鼠的缺陷型TGFβ1Ⅱ型受体基因序列,再利用基因重组技术,将其连接在真核表达质粒载体中,对此质粒载体进行酶切电泳鉴定和DNA测序加以验证。
2) Receptor model
受体模型
1.
Application and development of receptor models for the source apportionment of airborne particulate matter;
受体模型在大气颗粒物源解析中的应用和进展
2.
The chemical mass balance(CMB) model introduced by Miller in 1972 is one of the most frequently applied receptor models.
简述了大气颗粒物源解析技术的发展概况和化学质量平衡(CMB)受体模型的基本原理,对该模型应用中的关键问题,大气颗粒物源解析的进展情况作了详细的阐述。
3.
The pollution sources of TSP in center urban ambient air of Shuozhou city at five sites were analyzed by the chemical mass balance method(CMB) based on receptor model.
应用受体模型的化学质量平衡法对采暖期朔州市市区5个监测点的总悬浮颗粒物(TSP)进行污染源的源解析。
3) IP3 receptor typeⅠ
IP3Ⅰ型受体
1.
Objective:To probe for the possible mechanism of myocardial depression in endotoxic shock by establishing the animal model of endotoxic shock and detecting the change of the expression of IP3 receptor typeⅠand Ⅲ.
方法:股静脉注射脂多糖(LPS)建立内毒素休克动物模型,留取心脏标本用免疫组化方法检测大鼠心脏IP3Ⅰ型受体及Ⅲ型受体的表达。
4) IP3 receptor type Ⅲ
IP3Ⅲ型受体
5) AngⅡ type 1 receptor
AngⅡ1型受体
1.
TF, AngⅡ type 1 receptor (AT1) mRNA, NO synthase.
选择一个最佳浓度的通心络含药血浆预处理内皮细胞30min后加入AngⅡ10-6mol/L孵育HU-VECs24h观察TF,AngⅡ1型受体(AT1) mRNA水平,一氧化氮合酶(NOS)活性及一氧化氮浓度(NO),并予NOS抑制剂(L-NAME)预处理内皮细胞30min后,再加入通心络含药血浆和AngⅡ,观察孵育24h细胞活力,TF,AT1,NOS及NO变化。
6) subtypes
受体亚型
1.
This study,which was conducted in vitro,was to investigate the selective effects of l-6β-AN on the muscarinic cholinergic receptor and its subtypes on irises of rabbits,and to illuminated the mechanism of its action.
结果:l-6β-AN对离体虹膜括约肌呈现明显的浓度依赖性收缩,用选择性M受体拮抗剂研究表明,与虹膜收缩有关的受体亚型为M3受体。
补充资料：β1-受体
β1-受体
β-受体分出的一个亚型。β受体存在的效应器不同，对β-受体阻断药所产生的效应也不同。β1主要存在于心肌细胞上，能使心肌兴奋，脂肪分解代谢增加。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条